Mymetics (MYMX) Stock Price

Mymetics Price

OTC·CLOSED
0.00
​
Market closed

Revenue at Mymetics has contracted by 10.1% per year over the past 8 years to 1.03 M EUR. Mymetics's net margin stands at -467.4%, down from -431.4% several years earlier.

Mymetics stock price

Access this data via the Eulerpool API

Mymetics business model & stock analysis

Mymetics Corp. is a biotechnology company, which engages in the research and development of virosome based vaccines. The company is headquartered in Epalinges, Vaud and currently employs 8 full-time employees. The firm is focused on developing vaccines for infectious diseases. The firm has over five vaccine candidates in its pipeline: human immunodeficiency virus type 1 (HIV-1)/acquired immune deficiency syndrome (AIDS), intra nasal Influenza, Malaria, Herpes Simplex Virus (HSV) and the Respiratory Syncitial Virus (RSV) vaccine. Its technology utilizes virosomes, lipid-based carriers containing functional fusion viral proteins and natural membrane proteins, in combination with rationally designed antigens. Its prophylactic HIV-1 vaccine candidate is constituted of virosomes linked to conserved antigens derived from the HIV-1 glycoprotein 41 (gp41) proteins from the clade B. The RSV vaccine consists of the reconstituted membrane of RSV containing the native viral proteins. The HSV vaccine candidate consists of the reconstituted membrane of HSV-1 or HSV-2. The intranasal influenza vaccine includes the reconstituted membrane of influenza virus.

Frequently asked questions about Mymetics

The revenue cannot currently be calculated for Mymetics.

The profit cannot currently be calculated for Mymetics.

The P/E ratio cannot be calculated for Mymetics at the moment.

The P/S cannot be calculated for Mymetics currently.

The Eulerpool Quality Score for Mymetics is 3/10.

The ISIN of Mymetics is US62856A3005. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of Mymetics is 918588. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of Mymetics is MYMX. The ticker symbol is used to trade Mymetics shares on the stock exchange.

Fair ValueTerminal
0.00 EUR
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Biotechnology
Number of shares
Employees
Revenue per Employee
128,500.00 EUR
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website mymetics.com
Currency
EUR
Initial public offering
Feb 10, 1995
ISIN
US62856A3005
Cusip
62856A102
Sedol
2676090
Market capitalization
40.50 EURMicro Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/S
P/Se
—
EV/EBIT
—
P/B Ratio
—
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-69.00 %
Last updated Oct 8, 2026, 11:06 PM

All fundamentals and in-depth analysis of Mymetics

Our stock analysis for Mymetics stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Mymetics. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.